Alaunos Therapeutics, Inc.
TCRT
$1.46
-$0.02-1.35%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | 86.70% | 87.14% | 83.26% | 14.37% | 4.24% |
Total Depreciation and Amortization | -100.00% | -99.86% | -99.71% | -65.27% | -1.74% |
Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
Total Other Non-Cash Items | -96.23% | -93.26% | -83.19% | 413.89% | 131.37% |
Change in Net Operating Assets | 137.95% | 49.85% | 73.16% | -241.42% | -180.76% |
Cash from Operations | 87.75% | 75.99% | 79.57% | -3.58% | -3.73% |
Capital Expenditure | -- | -- | -- | 100.00% | 92.86% |
Sale of Property, Plant, and Equipment | -- | -- | -- | 6,434.78% | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | 1,716.13% | 107.14% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | -- | -100.00% | 100.00% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 87.75% | 91.21% | 87.68% | -570.18% | 22.90% |